Find the products and resources you are looking for!
Get in touch!
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec distribution:
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Cookie Settings
We use cookies in order to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement.
CD38 + plasma cells were isolated from human bone marrow using the Plasma Cell Isolation Kit II, an LD Column and a MidiMACS™ Separator, and two MS Columns and a MiniMACS™ Separator. Aliquots of the different cell fractions were fluorescently stained with CD19-APC and CD38-FITC for identification of plasma cells. |
Bone marrow before separation | Pre-enriched plasma cells after depletion of non-plasma cells |
Figure 1CD38 + plasma cells were isolated from human bone marrow using the Plasma Cell Isolation Kit II, an LD Column and a MidiMACS™ Separator, and two MS Columns and a MiniMACS™ Separator. Aliquots of the different cell fractions were fluorescently stained with CD19-APC and CD38-FITC for identification of plasma cells. | Figure 1CD38 + plasma cells were isolated from human bone marrow using the Plasma Cell Isolation Kit II, an LD Column and a MidiMACS™ Separator, and two MS Columns and a MiniMACS™ Separator. Aliquots of the different cell fractions were fluorescently stained with CD19-APC and CD38-FITC for identification of plasma cells. |
Enriched CD38+ plasma cells | |
Figure 1CD38 + plasma cells were isolated from human bone marrow using the Plasma Cell Isolation Kit II, an LD Column and a MidiMACS™ Separator, and two MS Columns and a MiniMACS™ Separator. Aliquots of the different cell fractions were fluorescently stained with CD19-APC and CD38-FITC for identification of plasma cells. |
CD38 + plasma cells were isolated from human bone marrow using the Plasma Cell Isolation Kit II, an LD Column and a MidiMACS™ Separator, and two MS Columns and a MiniMACS™ Separator. Aliquots of the different cell fractions were fluorescently stained with CD19-APC and CD38-FITC for identification of plasma cells. |
Bone marrow before separation | Pre-enriched plasma cells after depletion of non-plasma cells |
Figure 1CD38 + plasma cells were isolated from human bone marrow using the Plasma Cell Isolation Kit II, an LD Column and a MidiMACS™ Separator, and two MS Columns and a MiniMACS™ Separator. Aliquots of the different cell fractions were fluorescently stained with CD19-APC and CD38-FITC for identification of plasma cells. | Figure 1CD38 + plasma cells were isolated from human bone marrow using the Plasma Cell Isolation Kit II, an LD Column and a MidiMACS™ Separator, and two MS Columns and a MiniMACS™ Separator. Aliquots of the different cell fractions were fluorescently stained with CD19-APC and CD38-FITC for identification of plasma cells. |
Enriched CD38+ plasma cells | |
Figure 1CD38 + plasma cells were isolated from human bone marrow using the Plasma Cell Isolation Kit II, an LD Column and a MidiMACS™ Separator, and two MS Columns and a MiniMACS™ Separator. Aliquots of the different cell fractions were fluorescently stained with CD19-APC and CD38-FITC for identification of plasma cells. |
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.